Defining venous involvement in borderline resectable pancreatic cancer

Annals of Surgical Oncology

Volumn 17, Issue 11, 2010, Pages 2832-2838

  Chun, Yun Shin ^a   Milestone, Barton N ^a   Watson, James C ^a   Cohen, Steven J ^a   Burtness, Barbara ^a   Engstrom, Paul F ^a   Haluszka, Oleh ^a   Tokar, Jeffrey L ^a   Hall, Michael J ^a   Denlinger, Crystal S ^a   Astsaturov, Igor ^a   Hoffman, John P ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; GEMCITABINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CHILD; DISEASE CLASSIFICATION; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREATICODUODENECTOMY; PREOPERATIVE PERIOD; SUPERIOR MESENTERIC VEIN; SURVIVAL RATE; VEIN; VEIN OCCLUSION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MESENTERIC VEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PANCREAS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PORTAL VEIN; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78049462882     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1284-9     Document Type: Article

References (16)

1. DB Evans GR Varadhachary CH Crane, et al. 2008 Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head J Clin Oncol 26 3496 3502 1:CAS:528:DC%2BD1cXpvVWmtLo%3D 10.1200/JCO.2007.15.8634 18640930
2. S Raimondi P Maisonneuve AB Lowenfels 2009 Epidemiology of pancreatic cancer: an overview Nat Rev Gastroenterol Hepatol 6 699 708 10.1038/nrgastro. 2009.177 19806144
3. JG Fortner 1984 Regional pancreatectomy for cancer of the pancreas, ampulla, and other related sites. Tumor staging and results Ann Surg 199 418 425 1:STN:280:DyaL2c7nslKisw%3D%3D 10.1097/00000658-198404000-00008 6712317
4. MH Katz PW Pisters DB Evans, et al. 2008 Borderline resectable pancreatic cancer: the importance of this emerging stage of disease J Am Coll Surg. 206 833 846 10.1016/j.jamcollsurg.2007.12.020 18471707 (discussion 846-8)
5. National Comprehensive Cancer Network (NCCN). Clinical practice guidelines in oncology. Pancreatic adenocarcinoma. http://www.nccn.org/ professionals/physician-gls/default.asp. Accessed 27 Feb 2010.
6. RA Abrams AM Lowy EM O'Reilly RA Wolff VJ Picozzi PW Pisters 2009 Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement Ann Surg Oncol 16 1751 1756 10.1245/s10434-009-0413-9 19390900
7. O Ishikawa H Ohigashi S Imaoka, et al. 1992 Preoperative indications for extended pancreatectomy for locally advanced pancreas cancer involving the portal vein Ann Surg 215 231 236 1:STN:280:DyaK387otFaguw%3D%3D 10.1097/00000658-199203000-00006 1543394
8. KB Stitzenberg JC Watson A Roberts SA Kagan SJ Cohen AA Konski JP Hoffman 2008 Survival after pancreatectomy with major arterial resection and reconstruction Ann Surg Oncol 15 1399 1406 10.1245/s10434-008-9844-y 18320285
9. JF Pingpank JP Hoffman EA Ross, et al. 2001 Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas J Gastrointest Surg 5 121 130 1:STN:280: DC%2BD3Mzjt1Clsg%3D%3D 10.1016/S1091-255X(01)80023-8 11331473 (Pubitemid 33652049)
10. KM Brown V Siripurapu M Davidson, et al. 2008 Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma Am J Surg 195 318 321 1:CAS:528:DC%2BD1cXislSjsbY%3D 10.1016/j.amjsurg.2007.12.017 18308038 (Pubitemid 351625118)
11. CP Raut JF Tseng CC Sun, et al. 2007 Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma Ann Surg 246 52 60 10.1097/01.sla.0000259391.84304.2b 17592291 (Pubitemid 47012207)
12. Meszoely IM, Wang H, Hoffman JP. Preoperative chemoradiation therapy for adenocarcinoma of the pancreas: The Fox Chase Cancer Center experience, 1986-2003. Surg Oncol Clin N Am. 2004;13:685-96, x.
13. JF Tseng CP Raut JE Lee, et al. 2004 Pancreaticoduodenectomy with vascular resection: margin status and survival duration J Gastrointest Surg 8 935 949 10.1016/j.gassur.2004.09.046 15585381 (discussion 949-50) (Pubitemid 39600636)
14. G Butturini DD Stocken MN Wente, et al. 2008 Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials Arch Surg. 143 75 83 10.1001/archsurg.2007.17 18209156 (discussion 83) (Pubitemid 351159303)
15. RB Adams PJ Allen 2009 Surgical treatment of resectable and borderline resectable pancreatic cancer: expert consensus statement by Evans et al Ann Surg Oncol 16 1745 1750 10.1245/s10434-009-0410-z 19396494
16. RS Yeung JL Weese JP Hoffman, et al. 1993 Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A Phase II study Cancer. 72 2124 2133 1:STN:280:DyaK3szos1Kguw%3D%3D 10.1002/1097-0142(19931001)72:7<2124::AID- CNCR2820720711>3.0.CO;2-C 8374871